Blood-brain barrier permeability to four large neutral and one basic amino acid was studied in 30 pa tients with the double indicator technique. The resultant 64 venous outflow curves were analyzed by means of two models that take tracer backflux and capillary heteroge neity into account. The first model considers the blood brain barrier as a double membrane where amino acids from plasma enter the endothelial cell. When an endothe lial cell volume of 0.001 ml/g was assumed, permeability from the blood into the endothelial cell was, for most amino acids, about 10-20 times larger than the permeabil ity for the reverse direction. The second model assumes that the amino acids, after intracarotid injection, cross a single membrane barrier and enter a well-mixed compart ment, the brain extracellular fluid, i.e., the endothelial cell is assumed to behave as a single membrane. With this model, for large neutral amino acids, the permeability out
For determination of blood-brain barrier (BBB) permeability in humans, the double indicator method has commonly been used (Lassen et aI., 197 1; Hertz and Paulson, 1980) . Until recently, the analysis of the resultant venous outflow curves has been based on a single capillary model with one membrane between the blood and the brain tissue. For this model, it is obvious that for highly perme able substances such as propranolol (Hertz and Paulson, 1980) , the peak extraction will grossly un derestimate the unidirectional flux into the brain. of the extracellular fluid space back to the blood was between 8 to 12 times higher than the permeability from the blood into the brain. Such a difference in permeabil ities across the blood-brain barrier can almost entirely be ascribed to the effect of a nonlinear transport system combined with a relatively small brain amino acid metab olism. The significance of the possible presence of an energy-dependent A system at the abluminal side of the blood-brain barrier is discussed and related to the present findings. For both models, calculation of brain extraction by simple peak extraction values underestimates true uni directional brain uptake by 17-40%. This raises method ological problems when estimating blood to brain transfer of amino acids with this traditional in vivo method. Key Words: Blood-brain barrier-Amino acids-Perme ability-Double indicator method-Active transport.
However, underestimation is also a problem in the evaluation of less permeable substances, e.g., 0glucose (Knudsen et aI., 1990) . A model where backflux and heterogeneity of the cerebral vascular bed are taken into account has recently been devel oped and applied to the analysis of o-glucose (Knudsen et aI., 1990) .
In BBB studies in humans, we observed, in the shape of the tails of the venous outflow curves, a marked difference between o-glucose and some large neutral amino acids (LNAAs) ( Fig. O . LN AAs show much more rapid and pronounced backflux from the brain to the blood, yielding neg ative extraction values for the latter part of the curve. This difference could be due to either differ ences in the distribution volumes for o-glucose and LNAAs or differences in permeabilities of the lumi nal and abluminal membranes of the BBB. Active transport of LNAAs against the concentration gra dients across the BBB might be involved in such an asymmetrical transport. However, although the ability of some amino acids to leave the brain against substantial concentration gradients was noted more than 25 years ago (Lajhta and Toth, 1961) , no direct evidence for the underlying mech anism has been provided.
To investigate the backflux phenomenon of amino acids, double indicator data with four LNAAs (phenylalanine, tryptophan, leucine, and tyrosine) that are known to share the same trans port mechanism at the BBB and one basic amino acid (arginine) that has a separate transport mech anism for basic amino acids were analyzed by means of two models. The first model takes the endothelial cell volume into account by assuming that tracer substances go initially into a small, non mixed compartment (the endothelial cell). The other model assumes instead that amino acids go initially into a larger well-mixed compartment [the brain extracellular space (ECS)]. The present study deals with the interpretation of the results obtained with these two models.
MATERIALS AND METHODS

Patients
Thirty patients (19 women and 11 men, age 45 ± 15 years) hospitalized for various cerebral disorders requir ing carotid angiograms were studied in connection with the angiography after informed consent had been ob tained. The study had been approved by the National Ethical Committee. Patients with major cerebral lesions (e.g., larger tumors) that might interfere with BBB func tion were excluded.
After percutaneous punctures in the neck under local anesthesia, using the Seldinger technique, a small poly ethylene catheter (external diameter of 1.7 mm) was in troduced into one of the internal jugular veins. A second catheter (external diameter of 1.2 mm) was introduced into the internal carotid artery on the side appropriate for the angiogram. The tip of the venous catheter was placed in the superior bulb of the internal jugular vein; the tip of the arterial catheter was placed in the internal carotid artery just below the siphon. Correct positioning of the arterial catheter was verified by noting the absence of diffuse facial discoloration after a rapid injection of saline or Evans blue. At the end of the study, which usually lasted 2�30 min, the carotid catheter was used for diag nostic purposes.
Blood-brain barrier permeability measurements
For each determination of BBB permeability, a 1-2 ml bolus containing a test compound and several intravascu lar reference compounds was injected rapidly (1-2 s) through the indwelling intracarotid catheter. Starting a few seconds before the injection, a continuous series of 1.0 ml blood samples was collected from the venous cath eter by means of a sampling machine (Ole Dich Instru mentmakers, Hvidovre, Denmark) and deposited into dry heparinized tubes at a speed of 1 sample/so Isotopes The reference substances contained in each injected bolus were 100 ILCi 2 4N a + , 40 ILCi 113mIn-diethylenetri aminepentaacetic acid (DTP A), 2 ILCi 36Cl-, and 10 ILCi 14C-labeled L-lysine. L-lysine was used as a reference substance since it-as demonstrated by Hertz and Paul-son (1980) --does essentially not cross the human BBB within a single capillary passage. This observation is cu rious since lysine is an essential amino acid for the brain. At test substance, 40 ILCi 3 H-Iabeled or 10 ILCi 14C_ labeled substance (either L-phenylalanine, L-tyrosine, L tryptophan, L-Ieucine, or L-arginine) was used. z4Na + was obtained from Risl1\ (Denmark), DTPA from CIS In ternational (Quentin, France), and the other isotopes from Amersham Corp. (Arlington Heights, IL, U.S.A.) or NEN Chemicals (Dreieich, West Germany).
A standard solution was prepared from each bolus by adding an aliquot of injectate to venous blood sampled in a dry heparinized tube before the injection. When re peated studies of the BBB were performed, a time inter val of at least 10 min was allowed between measurements in order to decrease isotope background values in the samples.
All isotopes were counted in the plasma of the blood samples, the gamma and beta emitters being counted in the same sample. z4Na+ and 11 3 mIn were counted in a crystal scintillation counter (Packard Autogamma 5385, Packard Instrument Co., Downers Grove, IL, U.S.A.) and appropriate corrections for channel spillover and de cay were applied. Mter decay of the gamma emitters, 3 6CI, 3 H, and 14C were assayed using liquid scintillation counting (scintillation fluid: Instagel or Optifluor; spec trometer: Packard Tricarb 3375 or 4530) and corrections for quenching and channel spillover were applied using the method of external standardization.
The CBF was measured during each study using the 1 33 Xe intra-arterial injection method; 3-4 mCi of J 33 Xe dissolved in 2-3 ml of saline was injected rapidly (1-2 s) into the internal carotid artery through the indwelling catheter. The clearance of the isotope from the hemi sphere was followed by an externally positioned array of 16 small scintillation detectors; the average hemispheric blood flow was calculated from the initial slope of the semilogarithmically recorded clearance curves ).
Calculation of ideal reference curves
All venous outflow curves were normalized by dividing the count rate in each sample by the count rate in the standard solution to obtain comparable total areas under the venous outflow curves. Ideal reference curves were calculated in all cases in order to avoid the influence that intravascular separation of test and reference substances has on the relative shape of their venous outflow curves. The intravascular separation phenomena and methods that deal with these problems have been described in de tail elsewhere (Hertz and Paulson, 1980) .
In some of the studies, L-phenylalanine and L-tyrosine were compared with the reference substance, L-Iysine, which essentially remains in the cerebrovascular bed. Corrections for intravascular phenomena in these cases were not necessary because of similar molecular size and J Cereb Blood Flow Metab, Vol. 10, No. 5, 1990 erythrocyte permeability. In the remaining studies, N a + and In-DTP A were used as references after correction for differences in molecular size. The tested amino acids have molecular weights between that of Na + and that of In-DTP A, so the ideal reference for these substances was calculated as Na + + 0.5(In-DTPA -Na+ ). In every instance, corrections were minor.
Blood-brain barrier models and calculations
For the analysis of the kinetics of the movements of amino acids, two models were used to calculate the shape of a theoretical test curve from that of the reference curve when the CBF is known. In both models, tracer backflux and heterogeneity of the capillary transit times are taken into account. The estimates of the parameters that give the best fit to the test curve and their standard errors are obtained by finding the minimum sum of squared differ ences between the theoretical and the measured outflow test curve. The Simplex method was used to obtain the estimates of the parameters. The description of the mod els and the derivations of the operational equations have been described extensively in a previous paper (Knudsen et al., 1990) .
The double membrane model
The single capillary is surrounded by endothelial cells, which again are surrounded by the ECS of the brain (Fig.  2) . The BBB is a double membrane barrier that consists of a luminal and an abluminal endothelial cell membrane. This implies that different permeabilities in and out of the endothelial cell might be present. The parameters char acterizing the transfer of test substance across the BBB are the permeabilities or transfer rates from blood to en dothelial cell (PSI)' from endothelial cell to blood (PS z ), and from endothelial cell to ECS (PS 3 ). It is assumed that the substance concentration in the brain remains suffi ciently small so that the backflux from the brain to the endothelium is negligible. A fractional endothelial cell volume of 0.001 ml/g is assumed. The equations for the nonmixed model discussed in the previous paper (Knud sen et aI., 1990) are applicable to this model.
The operational equations for the double membrane model are where Cret<:t) and Ctest(t) are the amounts of the reference and test substances, respectively, as measured at the jug ular vein at time t. 9 is the total transit time and 9max is the value of 9 for which t -Tl(9) = 0, where TI(9) is the transit time through the large vessels and Te (9) is the tran sit time through the capillary bed for a given 9. Ce(y,t,Te) is the capillary concentration at position y at time t for a capillary transit time of T e and L is the length of the cap illary. The equation for Ce(L,t,Te) is given by (2) where 8 (0) is the Dirac delta bolus input, Vc is the cap illary volume, k2 3 = (PS2 + PS 3 )IVe, Ve is the endothelial cell volume, and 1\ is the imaginary Bessel function of the first kind of order one.
The single membrane model
This model assumes, due to the small size of the endo thelial cell, that the substance within the endothelial cell is almost immediately in a steady state with respect to the substance within the capillary and the brain ECS. Hence, the endothelial cell behaves as a single membrane (Fig.  2) . Thus, the parameters characterizing the transfer of substances across the BBB are the permeability of the endothelial cell from blood to the brain ECS (PSt), the permeability of the endothelial cell from brain ECS to blood (PS 2 ), and the permeability of the brain cell mem branes from the brain ECS into the brain cells (PS 3 ). In this model, it is assumed that the concentration within the brain cells remains sufficiently small so that there is neg ligible backflux from the cells to the brain ECS. The equa tions for the well-mixed model presented in the previous paper (Knudsen et al., 1990) are applicable for this model. 
where the LaPlace inverse is numerically evaluated (Knudsen et al., 1990) . In our previous paper, a distribu tion volume for o-glucose that was identical to the brain extracellular volume was found, i.e., 0.14 (Knudsen et al., 1990) . In this paper, it is assumed that amino acids, after intracarotid injection, distribute in the same space as o-glucose.
Statistics
For comparison of paired differences between the cal culated average unidirectional extraction E and the peak extraction of the curves Ep and between PS2 and PS 3 , the sign test was applied. The sign test was also used for comparison of the sum of squares obtained with the two models. Figure 1 illustrates representative examples of double indicator curves for D-glucose and L phenylalanine and the corresponding extraction plots. When 0.5 . (Na+ + In-DTPA) was used in stead of lysine as a reference for the amino acids, the values found for E, PSI' and Vd were similar, the maximum differences being less than 10%.
RESULTS
Tables 1 and 2 summarize the results obtained with the two models. For all amino acids, the sum of squares of differences between the test and the calculated test curves was smaller in the single membrane model as compared to the double mem brane model. The difference in the sum of squares, however, was not statistically significant. The dif ferences between the results obtained with either model were mainly due to the different assumed values of the distribution volumes. For both mod els, the PS2/PS3 ratio is independent of the distribu tion volume.
The peak extraction Ep is calculated as the mean of [([reference] -[testD/[reference]] at the three points around the peak of the outflow curves and included in both tables.
(3)
The double membrane model
With the double membrane model (Table 1) , PS2 and PS3 are calculated under the assumption that the distribution space for amino acids (Ve) is equal to the endothelial cell volume (0.001). PSI values are between 0.06 and 0.36 ml/g . min, with phenyl alanine and leucine having the highest values as compared to the other LNAAs. The basic amino acid, arginine, has the lowest values of PSI' PS2, and E. For all amino acids, PS2 values are between 0.004 and 0.018 ml/g . min, yielding PS/PS2 ratios between 12 and 21. PS3 as compared to PS2 is sig nificantly decreased for phenylalanine and tryp tophan (p < 0.0001 and p < 0.002, respectively). The PS2IPS3 ratios for the LNAAs are between 1.4 and 1.7, i.e., the carrier properties from the inside of the endothelial cell are on the same order of mag nitude. For arginine, PS3 values were often zero or close to zero, so the PS2IPS3 ratio is not determin able.
The single membrane model
Results from the single membrane model are shown in Table 2 . PSI values obtained from the first and second measurement when BBB permeability studies were repeated in the same patient are plot ted against each other in Fig. 3 . The correlation was highly significant (p < 0.000 1, r = 0.7). PSt for the different LNAAs varies between 0.06 and 0.36 mllg . min; E and PSI values for this model are also higher for phenylalanine and leucine and lower for arginine as compared to the LNAAs. Under the as sumption that the brain ECS (Ve) for the amino ac ids has a value of 0. 14, the median PS2 value for LNAAs is between 1.7 and 3.0 mllg . min, yielding a PS2/PSI ratio of between 8 and 12. For arginine, PS2 was 0.3 mllg . min and the PS2/PSt ratio was only 5. PS3 for the LNAAs is in the range of 0.9 to 1.8 mllg . min, largest for amino acids with large extractions. The PS2/PS3 ratio was consistently J Cereb Blood Flow Metab, Vol. 10, No.5, 1990 larger than 1, and the paired difference of PS2 and PS3 was statistically significant for phenylalanine and tryptophan (p < 0.000 1 and p < 0.002, respec tively).
Unidirectional extraction
For the double membrane model, Ep values are between 16 and 52% lower than the calculated E values. Statistically significant differences are only found for phenylalanine and for tryptophan (p < 0.0001). Even though Ep values in all patients were lower than E for all amino acids, significance was not obtained due to the small number of observa tions. For the single membrane model, Ep underes timates the calculated average extraction values by between 17 and 45%. For phenylalanine and tryp tophan, this difference is highly significant.
DISCUSSION
Double membrane model vs. single membrane model
With the endothelial cell model, the permeability for LNAAs is about 1(�20 times higher from the blood to the endothelial cell (PSI) than the perme ability from the endothelial cell back to the blood (PS2) or into the brain extracellular fluid (PS3). It is well known that facilitated transport of LN AAs acts on the plasma side of the BBB (Pardridge and 01dendorf, 1975), but the postulation of an energy requiring pump on this side would strongly disagree with previous findings. Furthermore, if there was no energy-requiring pump, the difference between PSI and PS2 might be explained by the transporter on the interior wall of the endothelial cells being saturated. However, this would imply that the con centrations of the LN AAs in the endothelial cells were much higher than those in the blood, even though it is a completely passive system and there is a net movement of the LNAAs from blood into brain. This would violate thermodynamic laws and thus is untenable.
In the single membrane model, it is found that PS2 is between 8 and 12 times larger than PSt. With this model, it is assumed that the distribution space for amino acids corresponds to that of D-glucose, and PS2 is subsequently calculated. Additionally, a glu cose study was performed on three of the patients from the present study. The distribution space for glucose was similar to those found in a previous study (Knudsen et al., 1990) . Alternatively, it could have been assumed that PSI = PS2 (corresponding to symmetrical transport properties across the BBB). A distribution volume could then be calcu lated and would amount to approximately 0.0 15. However, we are not able to define an anatomical Values are medians; quartiles are in brackets. n is the number of patients; number of double indicator studies is in brackets. E is the unidirectional extraction and E C is the peak extraction. a p < 0.000 1; p < 0.002; cp < 0.05 (PS2 vs. PS3 or E vs. Ep' sign test ) . space of this size, being about 10 times smaller than the cerebral extracellular volume and about 10 times larger than the endothelial cell volume, i.e., the single membrane model offers a suitable de scription provided that this asymmetry of the BBB can be justified. This topic will be discussed below.
BBB asymmetry
Cerebrospinal fluid concentrations of most amino acids are approximately 10 times lower than serum values, and in a dialysis probe study, the content of tryptophan in brain extracellular fluid has been found to be even lower, on the order of 1 % of the plasma values (Hutson et aI., 1986) . In the follow ing, we will discuss how this concentration gradient may be maintained by a relatively small metabolism combined with a nonlinear transport system. It should be emphasized that permeabilities across the BBB for carrier-transported substances are not fixed entities, but depend upon the concentration of the transported substances. The facilitated diffusion of amino acid that crosses the BBB is determined by Michaelis-Menten kinetics and has been de scribed by the following expressions (Gjedde and Christensen, 1984) :
Cp and Cb denote plasma and extracellular fluid amino acid concentrations, respectively, Kp and Kb are Km values for the plasma side and the brain side, respectively, and V m is the maximal transport ve locity for LNAAs. In the following, it is assumed that V m is identical for the amino acid transport in both directions across the BBB. A small nonsatura ble component of amino acid transport (Smith et al., 1987) probably also takes place in humans, but in the following it will, because of its insignificant con tribution in this context, be neglected.
Evidence from postmortem studies indicates that the human BBB for phenylalanine exhibits the same Km values as in rat brain, i.e., close to plasma con centrations and approximately 10 times lower than for other tissues (Choi and Pardridge, 1986) . Km values close to plasma concentrations lead to pro nounced competition between LN AAs that are transported across the BBB by means of the same carrier. The apparent Km, i.e., Km(app), resulting from competition between the LNAA is determined by the equation (Mahler and Cordes, 1966) where [AAJ is the amino acid concentration of a competing large neutral amino acid (i) and Km is the absolute Km for that large neutral amino add. As can be seen from Eqs. (5)-(7), competing LNAAs will increase the "apparent" Km on both mem branes, but mostly on the plasma side (with the Values are medians; quartiles are in brackets. n is the number of patients; number of double indicator studies is in brackets. E is the unidirectional extraction and E C is the peak extraction. a p < 0.000 1; P < 0.001; cp < 0.002 (PS2 vs. PS3 or E vs. Ep' sign test ) . higher amino acid concentrations), thus leading to an increase in the PS2IPS1 ratio. The PS2/PS1 ratio for thejth competing LNAA can be described using Eqs. (5)-(7) as giving a general solution for all competing LNAAs:
L -tyrosine
PS2,
That is, the relative permeabilities of a particular large neutral amino acid only depend upon the sum 1984) . K m values are from Miller et al. (1985) .
J Cereb Blood Flow Metab, Vol. 10, No.5, 1990 of all LNAAs on the two sides of the membrane. Therefore, the permeability ratio should be identi cal for all LNAAs.
Since the plasma and CSF concentrations of LNAAs in humans are known (Lentner, 1984a,b) and since Km values are known from experimental studies (Miller et al., 1985; Choi and Pardridge, 1986) , the PS2/PS1 ratio for the LNAAs that we have studied can be calculated. When values for Cp' Cb (Cb is now assumed to be equal to CSF concen trations), and Km for the competing LNAAs (phe nylalanine, tryptophan, methionine, tyrosine, leu cine, isoleucine, histidine, and valine) are inserted in Eq. (9), the ratio turns out to be 4.4. If the amino acid concentration in the extracellular fluid is lower than in CSF, the ratio will increase further. The highest possible value for the PS2IPS1 ratio is 7.8, which appears if extracellular fluid concentrations of LNAAs are zero. In the present study, we ob served a PS2/PS1 of between 8 and 12. The PS2IPS1 ratio for phenylalanine was by means of the paired Wilcoxon's text compared to the theoretical maxi mal value and increased significantly 7.8 times (p < 0.01).
Similar calculations could have been conducted
for the basic amino acids. Km for the basic amino acids, however, were not available. Tryptophan cir culates 80-90% bound to albumin and is the only amino acid with major protein binding properties. This means that the tryptophan free fraction, which is the fraction available for BBB transport, is much lower as compared to the total plasma concentra tion. Furthermore, since the ECS concentration of protein is much smaller than in plasma, this would tend to increase the PS2/PS1 ratio. A statistical eval uation of the ratio with comparison to the theoret ical maximal value was therefore not carried out for tryptophan.
Felig and co-workers (1973) determined the net transport of several amino acids into the human brain by calculation of the arteriovenous differ ences. For phenylalanine, the arteriovenous differ ence was 0.0038 mmollL and, assuming an average CBF value of 0.5 mllg . min, the result is a net in flux of 1.9 nmol/g . min. The unidirectional phenyl alanine brain influx can be determined from our re sults and equals PS1Cp, or 16 nmollg . min. Simi larly, for the other LNAAs, only 10 to 15% of the total amount that crosses the BBB is actually re tained and metabolized. These values are consistent with findings in animal studies (Pardridge et aI., 1975) . This relatively small amount of metabolized substrate, which to some extent may be combined with active transport out of the brain, is sufficient to maintain brain concentrations lower than in plasma. These concentration gradients across the BBB, along with the amplifying effect of a nonlinear trans port system as described above, leads to a much larger PSz than PSI' In the present study, we find a PSzIPS, ratio of about 12, i.e., the concentration gradients and diminished competition between LNAAs on the brain side, partly, but not fully, ex plain the PSzIPS, ratio. An energy-dependent car rier system on the brain side of the BBB might ad ditionally participate in maintaining low brain amino acid concentrations and could contribute to the high permeability out of the brain. If has originally been proposed by Christensen (1979) that two different carrier systems for the LNAAs, namely the Na + -independent, leucine preferring L system and the Na + -dependent, ala nine-preferring A system, are present. These sys tems have been observed in vitro in cerebral mi crovessels (Yudilevich et aI., 1972; Pardridge and Oldendorf, 1975; Betz and Goldstein, 1978; Har debo et aI., 1979; Cancilla and DeBault, 1983) .
K + -dependent phosphatase activity usually associ ated with Na+,K+-ATPase activity has been lo cated in the abluminal membrane; it has therefore been suggested that the energy-dependent A system is located only abluminally (Betz et aI., 1980 ). The A system is generally believed to prefer small neu tral amino acids (Betz and Goldstein, 1978; Tayrani et aI., 1987) ; but a cooperation between the A and the L systems has been demonstrated (Cangiano et aI., 1983; Cardelli-Cangiano et aI., 1987) . To date, no direct evidence for the existence of the systems in vivo in the cerebral capillaries has been found.
On the basis of the present findings, we now suggest that an energy-dependent carrier (the A system) lo cated at the abluminal membrane takes part in maintaining low amino acid concentrations in the extracellular fluid and increases the permeability out of the brain, whereby amino acids are success fully extruded to the blood. It should be noted that the smallest PSzIPS, ratio was observed for the ba sic amino acid, arginine. This finding is in accor dance with the belief that active transport is in volved only in the passage of LNAAs across the BBB.
Intracellular uptake in the single membrane model
For the single membrane model, intracellular up take from the ECS (PS3) is much faster for LN AAs than for D-glucose, where PS3 values are almost unmeasurable (Knudsen et aI., 1989) . From a phys iological point of view, a rapid uptake of LNAAs by neurons and glial cells could insure the cells a suf ficient supply of different LNAAs in spite of the low extracellular concentrations.
Peak extraction values
The extraction values for the two models (E) are calculated as the fractional unidirectional loss of test substance from the blood to the extracellular fluid/endothelial cells during a single passage through the cerebrovascular bed. They are diff erent from the traditionally calculated peak extraction values for total transfer from blood to the brain (Hertz and Paulson, 1980) . For LNAAs, backdiffu sion from the ECS/endothelial cells to the blood is pronounced and influences the venous outflow curves even before the peak of the curve, i.e., within less than 3 or 4 s after injection. In smaller animals such as the rat, backflux probably domi nates even earlier after a bolus injection. The ex traction values calculated by our present models are thus substantially higher than those traditionally calculated (Tables 1 and 2). Evidently, a method ological question of how to measure the penetration of amino acids into the cerebral tissue without un derestimating it is raised. Neglecting backflux from the ECS or the endothelium has been a problem with all previous methods attempting to estimate unidirectional blood to brain flux.
